Atrial fibrillation in patients with SARS-CoV-2 infection

被引:0
|
作者
Garcia-Granja, Pablo Elpidio [1 ,2 ]
Veras, Carlos [1 ]
Aparisi, Alvaro [1 ]
Amat-Santos, Ignacio J. [1 ,2 ]
Catala, Pablo [1 ]
Marcos, Marta [1 ]
Cabezon, Gonzalo [1 ]
Candela, Jordi [1 ]
Gil, Jose Francisco [1 ]
Uribarri, Aitor [1 ,2 ]
Revilla, Ana [1 ,2 ]
Carrasco, Manuel [1 ,2 ]
Gomez, Itziar [1 ,2 ]
Roman, Jose Alberto San [1 ,2 ]
机构
[1] Hosp Clin Univ Valladolid, Dept Cardiol, Inst Ciencias Corazon ICICOR, Valladolid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
来源
MEDICINA CLINICA | 2021年 / 157卷 / 02期
关键词
Atrial fibrillation; COVID-19; SARS-CoV-2; Hospital mortality; CORONAVIRUS; EPIDEMIOLOGY; MANAGEMENT; PNEUMONIA; PROGNOSIS; BURDEN;
D O I
10.1016/j.medcli.2021.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Resultados: De los 517 pacientes, 54 (10,4%) desarrollaron FA. Estos pacientes son mayores (81,6 vs. 66,5 an similar to os, p < 0,001) y presentan mas hipertension (74% vs. 47%, p < 0,001), miocardiopatia (9% vs. 1%, p = 0,002), ingreso previo por insuficiencia cardiaca (9% vs. 0,4%, p < 0,001), historia de FA (83% vs. 1%, p < 0,001) y mayor auricula izquierda (47,8 vs. 39,9 mm, p < 0,001). Los pacientes con FA presentan mas fallo respiratorio agudo (72% vs. 40%, p < 0,001) y mayor mortalidad hospitalaria (50% vs. 22%, p 0,001). Los predictores de FA son la edad y la historia de FA previa. La FA no es un predictor independiente de mortalidad hospitalaria. Los predictores son: edad, creatinina 1,5 mg/dL al ingreso, LDH > 250 U/L al ingreso y el fallo respiratorio agudo. Conclusion: La FA aparece en el 10% de los pacientes hospitalizados por SARS-CoV-2. Estos presentan mayor comorbilidad y el doble de mortalidad hospitalaria, pero la FA no es un factor pronostico indepen Introduction and objective: the SARS-CoV-2 infection ranges from asymptomatic to critical forms and several prognostic factors have been described. Atrial fibrillation (AF) is common in acute situations where it is linked with more complications and mortality. We aimed to evaluate the prognostic information of AF in this population. Methods: retrospective analysis of a cohort of 517 patients consecutively admitted in a tertiary hospital due to SARS-CoV-2 infection. We divided the patients in two groups according the development of AF and compared the main features of both groups. An univariable and multivariable analysis of mortality were also performed. Results: among 517 patients with SARS-CoV-2 infection admitted in a tertiary center, 54 (10.4%) developed AF. These patients are older (81.6 vs 66.5 years old, p < 0.001) and present more hypertension (74% vs 47%, p < 0.001), cardiomyopathy (9% vs 1%, p = 0.002), previous heart failure admission (9% vs 0.4%, p < 0.001), previous episodes of AF (83% vs 1%, p < 0.001) and bigger left atrium (47.8 vs 39.9 mm, p < 0.001). AF COVID-19 patients present more acute respiratory failure (72% vs 40%, p < 0.001) and higher in-hospital mortality (50% vs 22%, p < 0.001). Predictors of AF development are age and previous AF. AF is not an independent predictor of in-hospital mortality. Predictors are age, creatinine > 1.5 mg/dL at admission, LDH > 250 UI/L at admission and acute respiratory failure. Conclusion: Atrial fibrillation appears in 10% of hospitalized patients with SARS-CoV-2 infection. These patients present more comorbidities and two-fold increase in hospital mortality. Atrial fibrillation is not an independent prognostic factor. (c) 2021 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 50 条
  • [1] Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection
    Mountantonakis, Stavros E.
    Saleh, Moussa
    Fishbein, Joanna
    Gandomi, Amir
    Lesser, Martin
    Chelico, John
    Gabriels, James
    Qiu, Michael
    Epstein, Laurence M.
    HEART RHYTHM, 2021, 18 (04) : 501 - 507
  • [2] Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
    Rubini-Costa, Ricardo
    Bermudez-Jimenez, Francisco
    Rivera-Lopez, Ricardo
    Sola-Garcia, Elena
    Nagib-Raya, Hadi
    Moreno-Escobar, Eduardo
    Angel Lopez-Zuniga, Miguel
    Briones-Traves, Adela
    Sanz-Herrera, Francisco
    Miguel Sequi-Sabater, Jose
    Luis Romero-Cabrera, Juan
    Maillo-Seco, Javier
    Fernandez-Vazquez, Felipe
    Rivadeneira-Ruiz, Maria
    Lopez-Valero, Lucas
    Gomez-Navarro, Carlos
    Antonio Aparicio-Gomez, Jose
    Lopez, Miguel Alvarez
    Tercedor, Luis
    Molina-Jimenez, Maria
    Macias-Ruiz, Rosa
    Jimenez-Jaimez, Juan
    MEDICINA CLINICA, 2022, 158 (12): : 569 - 575
  • [3] Association between SARS-CoV-2 infection and new-onset atrial fibrillation
    Rosh, Bar
    Naoum, Ibrahim
    Barnett-Griness, Ofra
    Najjar-Debbiny, Ronza
    Saliba, Walid
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 392
  • [4] Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients
    Maloberti, Alessandro
    Giannattasio, Cristina
    Rebora, Paola
    Occhino, Giuseppe
    Ughi, Nicola
    Biolcati, Marco
    Gualini, Elena
    Rizzi, Jacopo Giulio
    Algeri, Michela
    Giani, Valentina
    Rossetti, Claudio
    Epis, Oscar Massimiliano
    Molon, Giulio
    Beltrame, Anna
    Bonfanti, Paolo
    Valsecchi, Maria Grazia
    Genovesi, Simonetta
    BIOMEDICINES, 2022, 10 (08)
  • [5] Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease
    Genovesi, Simonetta
    Rebora, Paola
    Occhino, Giuseppe
    Rossi, Emanuela
    Maloberti, Alessandro
    Belli, Michele
    Bonfanti, Paolo
    Giannattasio, Cristina
    Rossetti, Claudio
    Epis, Oscar Massimiliano
    Ughi, Nicola
    Valsecchi, Maria Grazia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [6] The mechanistic insights into new-onset atrial fibrillation induced by SARS-CoV-2 infection
    Xiao, Xiaoxia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 397
  • [7] Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
    Denegri, Andrea
    Morelli, Marianna
    Pezzuto, Giuseppe
    Malavasi, Vincenzo Livio
    Boriani, Giuseppe
    CARDIOLOGY JOURNAL, 2021, 28 (06) : 973 - 975
  • [8] The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
    Xia, Yong
    Hong, Honghai
    Feng, Yao
    Liu, Meiling
    Pan, Xingfei
    Chen, Dexiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 359 - 360
  • [9] SARS-COV-2 Presenting as New Onset Atrial Fibrillation: A Case Report
    Harhay, Jason
    Khan, Muniba
    Shah, Shalin
    Malhotra, Amit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [10] SARS-CoV-2 Infection in Patients with a History of VITT
    Schoenborn, Linda
    Seck, Sabrina E.
    Thiele, Thomas
    Warkentin, Theodore E.
    Greinacher, Andreas
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01): : 88 - 90